Back to Search
ALAN MOSS, MD
MD
Ophthalmology Physician
NPI: 1962502427Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Impact of concomitant immunomodulator use on long-term outcomes in patients receiving scheduled maintenance infliximab.
PMID 19533357·Dig Dis Sci·2010
8-other
Origins, actions and dynamic expression patterns of the neuropeptide VGF in rat peripheral and central sensory neurones following peripheral nerve injury.
PMID 19077191·Mol Pain·2008
7-preclinical
How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?
PMID 18816774·Inflamm Bowel Dis·2008
8-other
Steroid-refractory severe ulcerative colitis: what are the available treatment options?
PMID 18547130·Drugs·2008
6-review
The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.
PMID 18485127·Aliment Pharmacol Ther·2008
8-other
Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction.
PMID 17998839·Eur J Gastroenterol Hepatol·2007
4-observational
Gastrointestinal [corrected] stromal tumor of the ampulla of vater mimicking a duodenal ulcer.
PMID 17916534·Clin Gastroenterol Hepatol·2007
5-case
Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.
PMID 17412781·Gut·2007
7-preclinical
The risks and the benefits of mesalazine as a treatment for ulcerative colitis.
PMID 17367256·Expert Opin Drug Saf·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 255 PARK AVE, SUITE 606
WORCESTER, MA 01609 - Phone
- (508) 753-1032
Quick Facts
- NPI
- 1962502427
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile